Press Release: Filing of the 2024 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report
14 February 2025 - 6:08AM
Filing of the 2024 U.S. Form 20-F and French
“Document d’Enregistrement Universel” containing the Annual
Financial Report
Paris, February 13, 2025.
Sanofi announces today the filing of its Form 20-F with the U.S.
Securities and Exchange Commission (SEC) and its “Document
d’Enregistrement Universel” containing its Annual Financial Report
with the French market regulator Autorité des marchés financiers
(AMF).
These documents are available on the company’s
website:https://www.sanofi.com/en/investors/reports-and-publications/financial-reports-and-regulated-information
In addition, the Form 20-F is available on the
website of the SEC (www.sec.gov) and the “Document d’Enregistrement
Universel” is available on the website of the AMF
(www.amf-france.org). A hard copy of these documents, each of which
contains our complete audited financial statements, may be received
free of charge, upon request.
About Sanofi We are an innovative global
healthcare company, driven by one purpose: we chase the miracles of
science to improve people’s lives. Our team, across some 100
countries, is dedicated to transforming the practice of medicine by
working to turn the impossible into the possible. We provide
potentially life-changing treatment options and life-saving vaccine
protection to millions of people globally, while putting
sustainability and social responsibility at the center of our
ambitions. Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY
Media RelationsSandrine
Guendoul | + 33 6 25 09 14 25
| sandrine.guendoul@sanofi.comVictor
Rouault | + 33 6 70 93 71 40
| victor.rouault@sanofi.com
Investor RelationsThomas Kudsk
Larsen |+ 44 7545 513 693 |
thomas.larsen@sanofi.comAlizé Kaisserian | + 33 6
47 04 12 11 | alize.kaisserian@sanofi.comFelix
Lauscher | + 1 908 612 7239 |
felix.lauscher@sanofi.comKeita Browne | + 1 781
249 1766 | keita.browne@sanofi.comNathalie Pham |
+ 33 7 85 93 30 17 | nathalie.pham@sanofi.comTarik
Elgoutni | + 1 617 710 3587 |
tarik.elgoutni@sanofi.comThibaud Châtelet | + 33 6
80 80 89 90 | thibaud.chatelet@sanofi.com
Sanofi (EU:SAN)
Historical Stock Chart
From Jan 2025 to Feb 2025
Sanofi (EU:SAN)
Historical Stock Chart
From Feb 2024 to Feb 2025
